Background
Eucapnic voluntary hyperpnea (EVH) and methacholine inhalation test (MIT) are commonly used to evaluate airway responsiveness in athletes. EVH and MIT are frequently administered consecutively. However, it has been suggested that EVH could influence airway responsiveness to methacholine.
Objective/purpose
To evaluate the effects of EVH on the methacholine response in athletes with and without airway hyperresponsiveness (AHR) compared to control subjects.
Anzeige
Methods
Two MITs (one single and one preceded by EVH) were conducted in random order in 10 athletes with AHR (PC20 ≤ 16 mg/mL), 16 athletes without AHR (PC20 >16 mg/mL), and 11 control subjects.
Findings
In athletes with AHR, the PC20 (expressed as the mean of double concentrations (DC) ± standard error) was 0.7 ± 1.2 DC lower when MIT followed EVH (p = 0.015), while there was no significant difference in athletes without AHR (-0.4 ± 0.8 DC) nor in control subjects (0.4 ± 0.7 DC). When grouping subjects based on the EVH response, those with a positive response (FEV1 fall ≥ 10%) had a mean PC20 0.8 ± 1.1 DC lower when MIT followed EVH (p = 0.0008) while in those with no response to EVH (FEV1 fall <10%), airway responsiveness was not influenced by this test (0.05 ± 0.76 DC).
Deliverables
EVH slightly increases the response to the subsequent MIT in athletes with AHR to methacholine or with a positive response to EVH, but not in those without AHR, nor in control subjects. These two challenges should, therefore, be conducted in two different sessions.
Relevance
This research is in accordance with AllerGen's mission because, by bringing to light the importance of proceeding with the bronchial challenges in two different sessions, it ensures reliable test results. These findings are going to be submitted to a scientific journal for publication.
Anzeige
Open AccessThis article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.